Health, risks and disease in therapeutic functionalities of Glucagon-like peptide-1 receptoragonists (GLP-1RAs) concerning human susceptibility. (2025). Greenfort International Journal of Applied Medical Science, 3(5), 240-254. https://doi.org/10.62046/gijams.2025.v03i05.002